Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

1.20
Delayed Data
As of Aug 18
 -0.04 / -3.23%
Today’s Change
1.13
Today|||52-Week Range
4.62
-56.76%
Year-to-Date

Today’s Trading

Previous close1.24
Today’s open1.23
Day’s range1.20 - 1.25
Volume1,236,324
Average volume (3 months)2,418,601
Market cap$159.4M
Dividend yield87.94%
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+9.02%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+61.64%
P/E ratioNM
Price/Sales3.54
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OMEDOncoMed Pharmaceutic...-0.06-1.39%
STDYSteadymed Ltd+0.10+1.67%
OVIDOvid Therapeutics In...+0.01+0.16%
VRNAVerona Pharma PLC+0.18+1.50%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$144.3M
Annual profit (last year)-$151.7M
Net profit margin-105.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Richard Peters
Head-
Research
Daryl Drummond
Corporate headquarters
Cambridge, Massachusetts

Forecasts